Cargando…

Liver transaminase concentrations in children with acute SARS-CoV-2 infection

OBJECTIVE: To evaluate the relationship between SARS-CoV-2 infection and liver injury by comparing transaminase concentrations among children tested for SARS-CoV-2 and other respiratory viruses in pediatric emergency departments. DESIGN & METHODS: Eligible children were <18 years with suspect...

Descripción completa

Detalles Bibliográficos
Autores principales: Sumner, Madeleine W., Florin, Todd A., Kuppermann, Nathan, Xie, Jianling, Tancredi, Daniel J., Freedman, Stephen B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228160/
https://www.ncbi.nlm.nih.gov/pubmed/37263559
http://dx.doi.org/10.1016/j.clinbiochem.2023.110588
_version_ 1785050910610685952
author Sumner, Madeleine W.
Florin, Todd A.
Kuppermann, Nathan
Xie, Jianling
Tancredi, Daniel J.
Freedman, Stephen B.
author_facet Sumner, Madeleine W.
Florin, Todd A.
Kuppermann, Nathan
Xie, Jianling
Tancredi, Daniel J.
Freedman, Stephen B.
author_sort Sumner, Madeleine W.
collection PubMed
description OBJECTIVE: To evaluate the relationship between SARS-CoV-2 infection and liver injury by comparing transaminase concentrations among children tested for SARS-CoV-2 and other respiratory viruses in pediatric emergency departments. DESIGN & METHODS: Eligible children were <18 years with suspected SARS-CoV-2, tested using molecular approaches in emergency departments between March 7, 2020, and June 15, 2021 (Pediatric Emergency Research Network), and between August 6, 2020, and February 22, 2022 (Pediatric Emergency Research Canada). We compared aspartate (AST) and alanine aminotransferase (ALT) concentrations at presentation for SARS-CoV-2 and other respiratory viruses through a multivariate linear regression model, with the natural log of serum transaminase concentrations as dependent variables. RESULTS: Of 16,892 enrolled children, 2,462 (14.6%) had transaminase concentrations measured; 4318 (25.6%) were SARS-CoV-2 positive, and 3932 (23.3%) were tested for additional respiratory viruses. Among study participants who had additional respiratory virus testing performed, the most frequently identified viruses were enterovirus/rhinovirus [8.7% (343/3,932)], respiratory syncytial virus [4.6% (181/3,932)], and adenovirus [2.6% (103/3,932)]. Transaminase concentrations were elevated in 25.6% (54/211) of children with isolated SARS-CoV-2 detection and 21.6% (117/541) of those with no virus isolated; P = 0.25. In the multivariable model, isolated SARS-CoV-2 detection was not associated with elevated ALT (adjusted geometric mean ratio (IU/L): 0.96; 95%Confidence Interval (CI): 0.84, 1.08) or AST (adjusted geometric mean ratio (IU/L): 1.03; 95%CI: 0.92, 1.16) concentrations, with negative respiratory panel as the referent group. Ninety-day follow-up was completed in 82.2% (3,550/4,318) of SARS-CoV-2 positive children; no cases of new-onset liver disease were reported. CONCLUSION: Among those tested, transaminase concentrations did not vary between SARS-CoV-2-positive children and those with a negative respiratory viral panel. In multivariate analysis, SARS-CoV-2 infection was not associated with increased initial transaminase concentrations compared to other respiratory viruses.
format Online
Article
Text
id pubmed-10228160
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Authors. Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.
record_format MEDLINE/PubMed
spelling pubmed-102281602023-05-30 Liver transaminase concentrations in children with acute SARS-CoV-2 infection Sumner, Madeleine W. Florin, Todd A. Kuppermann, Nathan Xie, Jianling Tancredi, Daniel J. Freedman, Stephen B. Clin Biochem Short Communication OBJECTIVE: To evaluate the relationship between SARS-CoV-2 infection and liver injury by comparing transaminase concentrations among children tested for SARS-CoV-2 and other respiratory viruses in pediatric emergency departments. DESIGN & METHODS: Eligible children were <18 years with suspected SARS-CoV-2, tested using molecular approaches in emergency departments between March 7, 2020, and June 15, 2021 (Pediatric Emergency Research Network), and between August 6, 2020, and February 22, 2022 (Pediatric Emergency Research Canada). We compared aspartate (AST) and alanine aminotransferase (ALT) concentrations at presentation for SARS-CoV-2 and other respiratory viruses through a multivariate linear regression model, with the natural log of serum transaminase concentrations as dependent variables. RESULTS: Of 16,892 enrolled children, 2,462 (14.6%) had transaminase concentrations measured; 4318 (25.6%) were SARS-CoV-2 positive, and 3932 (23.3%) were tested for additional respiratory viruses. Among study participants who had additional respiratory virus testing performed, the most frequently identified viruses were enterovirus/rhinovirus [8.7% (343/3,932)], respiratory syncytial virus [4.6% (181/3,932)], and adenovirus [2.6% (103/3,932)]. Transaminase concentrations were elevated in 25.6% (54/211) of children with isolated SARS-CoV-2 detection and 21.6% (117/541) of those with no virus isolated; P = 0.25. In the multivariable model, isolated SARS-CoV-2 detection was not associated with elevated ALT (adjusted geometric mean ratio (IU/L): 0.96; 95%Confidence Interval (CI): 0.84, 1.08) or AST (adjusted geometric mean ratio (IU/L): 1.03; 95%CI: 0.92, 1.16) concentrations, with negative respiratory panel as the referent group. Ninety-day follow-up was completed in 82.2% (3,550/4,318) of SARS-CoV-2 positive children; no cases of new-onset liver disease were reported. CONCLUSION: Among those tested, transaminase concentrations did not vary between SARS-CoV-2-positive children and those with a negative respiratory viral panel. In multivariate analysis, SARS-CoV-2 infection was not associated with increased initial transaminase concentrations compared to other respiratory viruses. The Authors. Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists. 2023-08 2023-05-30 /pmc/articles/PMC10228160/ /pubmed/37263559 http://dx.doi.org/10.1016/j.clinbiochem.2023.110588 Text en © 2023 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Communication
Sumner, Madeleine W.
Florin, Todd A.
Kuppermann, Nathan
Xie, Jianling
Tancredi, Daniel J.
Freedman, Stephen B.
Liver transaminase concentrations in children with acute SARS-CoV-2 infection
title Liver transaminase concentrations in children with acute SARS-CoV-2 infection
title_full Liver transaminase concentrations in children with acute SARS-CoV-2 infection
title_fullStr Liver transaminase concentrations in children with acute SARS-CoV-2 infection
title_full_unstemmed Liver transaminase concentrations in children with acute SARS-CoV-2 infection
title_short Liver transaminase concentrations in children with acute SARS-CoV-2 infection
title_sort liver transaminase concentrations in children with acute sars-cov-2 infection
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228160/
https://www.ncbi.nlm.nih.gov/pubmed/37263559
http://dx.doi.org/10.1016/j.clinbiochem.2023.110588
work_keys_str_mv AT sumnermadeleinew livertransaminaseconcentrationsinchildrenwithacutesarscov2infection
AT florintodda livertransaminaseconcentrationsinchildrenwithacutesarscov2infection
AT kuppermannnathan livertransaminaseconcentrationsinchildrenwithacutesarscov2infection
AT xiejianling livertransaminaseconcentrationsinchildrenwithacutesarscov2infection
AT tancredidanielj livertransaminaseconcentrationsinchildrenwithacutesarscov2infection
AT freedmanstephenb livertransaminaseconcentrationsinchildrenwithacutesarscov2infection
AT livertransaminaseconcentrationsinchildrenwithacutesarscov2infection